FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for LATANOPROST submitted by Mylan Pharmaceuticals Inc. The approval pertains to latanoprost, a therapy used to treat glaucoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)